Michael Atkins
Fortuna: 6 489 $ al 31/05/2026
Fortuna: 6 489 $ al 31/05/2026
Michael B. Atkins currently holds the positions of Director at Melanoma Research Foundation, Independent Director at Werewolf Therapeutics, Inc. since 2024, President at Society For Immunotherapy of Cancer, and Professor at Harvard Medical School since 2002.
Dr. Atkins completed undergraduate education at Tufts University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 12/06/2025 | 14.419 ( 0,03 % ) | 6 489 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| WEREWOLF THERAPEUTICS, INC. | Director/Miembro de la Junta | 04/01/2024 |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Director/Miembro de la Junta | - |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2002 |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Presidente | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Tufts University
Tufts University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Melanoma Research Foundation
Melanoma Research Foundation Miscellaneous Commercial ServicesCommercial Services Operates medical research foundation | Commercial Services |
Werewolf Therapeutics, Inc.
Werewolf Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer | Health Technology |
Society For Immunotherapy of Cancer
Society For Immunotherapy of Cancer Miscellaneous Commercial ServicesCommercial Services Operates as a member-driven organization specifically dedicated to improving cancer patient outcomes | Commercial Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.